{"transactions":[{"id":1129162,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:40:38.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019049","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019049/rdgdoc.xml","form_type":"4"}},{"id":1515870,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T01:28:19.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":39200,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001437749-24-017187","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924017187/rdgdoc.xml","form_type":"4"}},{"id":1549734,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:49:49.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":3253,"price":4.54,"value":14768.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 14, 2024."}],"balance_after":38054,"source":{"system":"sec-edgar","filing":"0001415889-24-010213","document":"form4-04042024_120440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924010213/form4-04042024_120440.xml","form_type":"4"}},{"id":1709321,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:40:21.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":4043,"price":2.73,"value":11037.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 14, 2023."}],"balance_after":34801,"source":{"system":"sec-edgar","filing":"0001415889-23-016532","document":"form4-12152023_091215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588923016532/form4-12152023_091215.xml","form_type":"4"}},{"id":1778935,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T21:25:49.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":2986,"price":3.6,"value":10749.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 14, 2023."}],"balance_after":30758,"source":{"system":"sec-edgar","filing":"0001415889-23-013337","document":"form4-09182023_090941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588923013337/form4-09182023_090941.xml","form_type":"4"}},{"id":1849153,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T17:26:56.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":12787,"derivative":{"exercise_price":30.33,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12787},"source":{"system":"sec-edgar","filing":"0001655759-23-000063","document":"wk-form4_1687296408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000165575923000063/wk-form4_1687296408.xml","form_type":"4"}},{"id":1849152,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T17:26:56.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":4121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":9121,"source":{"system":"sec-edgar","filing":"0001655759-23-000063","document":"wk-form4_1687296408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000165575923000063/wk-form4_1687296408.xml","form_type":"4"}},{"id":1852352,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T21:41:57.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":5119,"price":2.1,"value":10749.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 15, 2023."}],"balance_after":27772,"source":{"system":"sec-edgar","filing":"0001415889-23-009960","document":"form4-06162023_090654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588923009960/form4-06162023_090654.xml","form_type":"4"}},{"id":1889101,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-18T01:07:17.000Z","date":"2023-05-16","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 16, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":16500,"derivative":{"exercise_price":1.82,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-23-008242","document":"form4-05182023_010509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588923008242/form4-05182023_010509.xml","form_type":"4"}},{"id":1900839,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-09T01:50:42.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":36300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 3, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer."}],"balance_after":36300,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":36300},"source":{"system":"sec-edgar","filing":"0001437749-23-013123","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923013123/rdgdoc.xml","form_type":"4"}},{"id":1900838,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-09T01:50:42.000Z","date":"2023-04-25","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, April 25, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer."}],"balance_after":22500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-04-24","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001437749-23-013123","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923013123/rdgdoc.xml","form_type":"4"}},{"id":1944546,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T20:34:01.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":6437,"price":1.67,"value":10749.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 16, 2023."}],"balance_after":22653,"source":{"system":"sec-edgar","filing":"0001415889-23-005219","document":"form4-03202023_080355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588923005219/form4-03202023_080355.xml","form_type":"4"}},{"id":2081726,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T02:15:10.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":7167,"price":1.5,"value":10750.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022."}],"balance_after":16216,"source":{"system":"sec-edgar","filing":"0001415889-22-012796","document":"form4-12202022_021201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922012796/form4-12202022_021201.xml","form_type":"4"}},{"id":2155779,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T21:10:56.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":4103,"price":2.62,"value":10749.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 15, 2022."}],"balance_after":9049,"source":{"system":"sec-edgar","filing":"0001415889-22-009774","document":"form4-09192022_020947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922009774/form4-09192022_020947.xml","form_type":"4"}},{"id":2218706,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-30T20:07:12.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":4946,"price":2.03,"value":10040.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 16, 2022."}],"balance_after":4946,"source":{"system":"sec-edgar","filing":"0001415889-22-007101","document":"form4a-06302022_010603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922007101/form4a-06302022_010603.xml","form_type":"4/A","original_submission_date":"2022-06-17"}},{"id":2225147,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:00:54.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":10192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 16, 2022. The shares underlying the award shall vest in full on the earlier of June 16, 2023 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":10192,"derivative":{"exercise_price":36.79,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10192},"source":{"system":"sec-edgar","filing":"0001209191-22-038560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000120919122038560/doc4.xml","form_type":"4"}},{"id":2227960,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:26:17.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":4060,"price":2.03,"value":8241.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 16, 2022."}],"balance_after":4060,"source":{"system":"sec-edgar","filing":"0001415889-22-006740","document":"form4-06172022_010651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922006740/form4-06172022_010651.xml","form_type":"4"}},{"id":2229700,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2022-06-16T16:56:08.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":7585,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7585},"source":{"system":"sec-edgar","filing":"0001127602-22-017636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760222017636/form4.xml","form_type":"4"}},{"id":2229699,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-06-16T16:56:08.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":7585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":53124,"source":{"system":"sec-edgar","filing":"0001127602-22-017636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760222017636/form4.xml","form_type":"4"}},{"id":2232526,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2022-06-14T21:01:17.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":51204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":51204,"derivative":{"underlying":"Common Stock","underlying_shares":51204},"source":{"system":"sec-edgar","filing":"0001104659-22-071050","document":"tm2218366-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922071050/tm2218366-2_4seq1.xml","form_type":"4"}},{"id":2234205,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T23:01:47.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 7, 2023 or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.14,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-006514","document":"form4-06132022_040639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922006514/form4-06132022_040639.xml","form_type":"4"}},{"id":2301303,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-07T20:16:34.000Z","date":"2022-04-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments, with the first installment vesting on May 6, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.04,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-003940","document":"form4-04072022_010423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922003940/form4-04072022_010423.xml","form_type":"4"}},{"id":2309729,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:00:32.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":249,"price":79.42,"value":19775.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17768,"source":{"system":"sec-edgar","filing":"0001209191-22-022285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122022285/doc4.xml","form_type":"4"}},{"id":2451968,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:15:24.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":260,"price":73.4,"value":19084.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17519,"source":{"system":"sec-edgar","filing":"0001209191-22-000697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122000697/doc4.xml","form_type":"4"}},{"id":2458961,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2021-12-27T21:11:15.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Beginning May 30, 2012, options become exercisable in full on May 30, 2013."}],"balance_after":0,"derivative":{"exercise_price":73.25,"expiration_date":"2022-05-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-071241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121071241/doc4.xml","form_type":"4"}},{"id":2458960,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T21:11:15.000Z","date":"2021-12-23","kind":"sale","acquired":false,"shares":20000,"price":22.05,"value":441000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17259,"source":{"system":"sec-edgar","filing":"0001209191-21-071241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121071241/doc4.xml","form_type":"4"}},{"id":2458959,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T21:11:15.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":20000,"price":73.25,"value":1465000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average sale price. Actual sale prices ranged from $73.01 - $73.54. Reporting person undertakes to provide upon request\nby Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of\nshares sold within range indicated."}],"balance_after":37259,"source":{"system":"sec-edgar","filing":"0001209191-21-071241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121071241/doc4.xml","form_type":"4"}},{"id":2485252,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-12-03T21:22:02.000Z","date":"2021-12-02","kind":"exercise","acquired":false,"shares":5578,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5578},"source":{"system":"sec-edgar","filing":"0001127602-21-030301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221030301/form4.xml","form_type":"4"}},{"id":2485251,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-12-03T21:22:02.000Z","date":"2021-12-02","kind":"tax_withholding","acquired":false,"shares":1339,"price":22.11,"value":29605.29,"ownership":{"direct":true},"balance_after":45539,"source":{"system":"sec-edgar","filing":"0001127602-21-030301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221030301/form4.xml","form_type":"4"}},{"id":2485250,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-12-03T21:22:02.000Z","date":"2021-12-02","kind":"exercise","acquired":true,"shares":5578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":46878,"source":{"system":"sec-edgar","filing":"0001127602-21-030301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221030301/form4.xml","form_type":"4"}},{"id":2506801,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 15, 2021 and shall vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of the stockholders. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F12","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 15, 2021 and shall vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of the stockholders. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 15, 2021 and shall vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of the stockholders. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":10038,"derivative":{"exercise_price":16.36,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":10038},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506800,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 18, 2020 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 18, 2020 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 18, 2020 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":2953,"derivative":{"exercise_price":31.93,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":2953},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506799,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 6, 2019 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F10","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 6, 2019 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 6, 2019 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":3938,"derivative":{"exercise_price":60.78,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":3938},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506798,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 20, 2018 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 20, 2018 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 20, 2018 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":3938,"derivative":{"exercise_price":91.2,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":3938},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506797,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 8, 2017 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 8, 2017 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 8, 2017 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":3938,"derivative":{"exercise_price":55.29,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":3938},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506796,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 2, 2016 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 2, 2016 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 2, 2016 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":3938,"derivative":{"exercise_price":23.85,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":3938},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506795,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 4, 2015 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 4, 2015 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 4, 2015 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":7384,"derivative":{"exercise_price":92.14,"expiration_date":"2025-06-04","underlying":"Common Stock","underlying_shares":7384},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506794,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 11, 2014 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 11, 2014 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on June 11, 2014 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":7384,"derivative":{"exercise_price":12.54,"expiration_date":"2024-06-11","underlying":"Common Stock","underlying_shares":7384},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506793,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":26361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on April 29, 2013 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on April 29, 2013 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options to purchase bluebird common stock awarded to the reporting person prior to the Separation. In connection with the Separation, the shares of common stock underlying this award were adjusted pursuant to the EMA such that the reporting person received options to purchase shares of 2seventy common stock to preserve the value associated with the original award (see footnotes 2 and 3). This option was originally granted on April 29, 2013 and is fully vested and exercisable as of the date hereof. The exercise price of the option has been adjusted based on the conversion ratio described in footnotes 2 and 3."}],"balance_after":25953,"derivative":{"exercise_price":4.07,"expiration_date":"2023-04-29","underlying":"Common Stock","underlying_shares":25953},"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2506792,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T08:57:25.000Z","date":"2021-11-11","kind":"other","acquired":true,"shares":6241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units awarded to the reporting person prior to the separation (the \"Separation\") of 2seventy bio, Inc. (\"2seventy\") from bluebird bio, Inc. (\"bluebird\"). In connection with the Separation, the restricted stock units underlying this award were adjusted pursuant to the Employee Matters Agreement by and between 2seventy and bluebird (the \"EMA\") to preserve the value associated with the original restricted stock unit award (see footnotes 2 and 3). This restricted stock unit award was originally granted on June 15, 2021 and vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders."},{"field":"security","element":"securityTitle","label":"F2","text":"bluebird equity awards granted prior to January 1, 2021 were converted into equity awards of both bluebird and 2seventy. The number of shares underlying the converted bluebird equity awards was determined by multiplying the number of shares underlying the existing bluebird equity award by a fraction, the numerator of which is the volume-weighted average trading price of bluebird common stock (trading \"regular way\") on the five trading days immediately prior to the distribution date (the \"bluebird Pre-Distribution VWAP\") and the denominator of which is the sum of (1) the volume-weighted average trading price of 2seventy common stock (trading \"regular way\") on the five trading days immediately following the distribution date multiplied by the distribution ratio and (2) the volume-weighted average trading price of bluebird bio common stock (trading \"regular way\") on the five trading days immediately following the distribution date (the \"bluebird Post-Distribution VWAP\")."},{"field":"security","element":"securityTitle","label":"F3","text":"bluebird equity awards granted on or after January 1, 2021, such equity awards continued as bluebird equity awards, subject to adjustment. The adjusted number of shares of bluebird common stock underlying such equity awards is equal to the number of shares of bluebird common stock subject to the equity award immediately prior to the distribution multiplied by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the bluebird Post-Distribution VWAP."}],"balance_after":11894,"source":{"system":"sec-edgar","filing":"0001628280-21-023650","document":"wf-form4_163715742952211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000162828021023650/wf-form4_163715742952211.xml","form_type":"4"}},{"id":2553176,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:28:51.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":244,"price":68.78,"value":16782.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17259,"source":{"system":"sec-edgar","filing":"0001209191-21-058967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121058967/doc4.xml","form_type":"4"}},{"id":2646195,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T11:23:07.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":214,"price":84.13,"value":18003.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17015,"source":{"system":"sec-edgar","filing":"0001209191-21-044646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121044646/doc4.xml","form_type":"4"}},{"id":2663347,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T16:09:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders."}],"balance_after":5000,"derivative":{"exercise_price":32.83,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-21-004351","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218021004351/primarydocument.xml","form_type":"4"}},{"id":2663346,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T16:09:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":3109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders."}],"balance_after":8762,"source":{"system":"sec-edgar","filing":"0001562180-21-004351","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218021004351/primarydocument.xml","form_type":"4"}},{"id":2665884,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-06-16T16:25:14.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":7585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/14/2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/14/2022."}],"balance_after":7585,"derivative":{"exercise_date":"2022-06-14","underlying":"Ordinary Shares","underlying_shares":7585},"source":{"system":"sec-edgar","filing":"0001127602-21-020042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221020042/form4.xml","form_type":"4"}},{"id":2665883,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-06-16T16:25:14.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":15677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 6/14/2022."}],"balance_after":15677,"derivative":{"exercise_price":24.72,"exercise_date":"2022-06-14","expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":15677},"source":{"system":"sec-edgar","filing":"0001127602-21-020042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221020042/form4.xml","form_type":"4"}},{"id":2671544,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-06-11T16:37:32.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":18.21,"expiration_date":"2022-08-01","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-21-019722","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221019722/form4.xml","form_type":"4"}},{"id":2671543,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-06-11T16:37:32.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":25000,"price":25,"value":625000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":41300,"source":{"system":"sec-edgar","filing":"0001127602-21-019722","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221019722/form4.xml","form_type":"4"}},{"id":2671542,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-06-11T16:37:32.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":25000,"price":18.21,"value":455250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":66300,"source":{"system":"sec-edgar","filing":"0001127602-21-019722","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221019722/form4.xml","form_type":"4"}},{"id":2673614,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-10T20:00:15.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":7511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders."}],"balance_after":7511,"derivative":{"exercise_price":78.53,"expiration_date":"2021-06-07","underlying":"Common Stock","underlying_shares":7511},"source":{"system":"sec-edgar","filing":"0001209191-21-039671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000120919121039671/doc4.xml","form_type":"4"}},{"id":2692174,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-28T11:06:45.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":8010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":8010,"derivative":{"exercise_price":83.16,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":8010},"source":{"system":"sec-edgar","filing":"0001209191-21-036403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036403/doc4.xml","form_type":"4"}},{"id":2692173,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T11:06:45.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":1923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":16801,"source":{"system":"sec-edgar","filing":"0001209191-21-036403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036403/doc4.xml","form_type":"4"}},{"id":2700556,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-05-21T16:34:52.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This restricted stock unit award vested in full on 5/20/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This restricted stock unit award vested in full on 5/20/2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-21-017786","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221017786/form4.xml","form_type":"4"}},{"id":2700555,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-05-21T16:34:52.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":1404,"price":21.92,"value":30775.68,"ownership":{"direct":true},"balance_after":41300,"source":{"system":"sec-edgar","filing":"0001127602-21-017786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221017786/form4.xml","form_type":"4"}},{"id":2700554,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-05-21T16:34:52.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42704,"source":{"system":"sec-edgar","filing":"0001127602-21-017786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221017786/form4.xml","form_type":"4"}},{"id":2743877,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-04-20T19:22:36.000Z","date":"2021-04-19","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":14.6,"expiration_date":"2021-10-05","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-21-014126","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221014126/form4.xml","form_type":"4"}},{"id":2743876,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-04-20T19:22:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":25000,"price":20.0048,"value":500120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":36600,"source":{"system":"sec-edgar","filing":"0001127602-21-014126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221014126/form4.xml","form_type":"4"}},{"id":2743875,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-04-20T19:22:36.000Z","date":"2021-04-19","kind":"exercise","acquired":true,"shares":25000,"price":14.6,"value":365000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":61600,"source":{"system":"sec-edgar","filing":"0001127602-21-014126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221014126/form4.xml","form_type":"4"}},{"id":2765262,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-01T21:09:25.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":225,"price":81.27,"value":18285.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14878,"source":{"system":"sec-edgar","filing":"0001209191-21-024154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121024154/doc4.xml","form_type":"4"}},{"id":2905679,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-01-15T16:38:31.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":12.62,"expiration_date":"2021-01-13","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-21-001770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221001770/form4.xml","form_type":"4"}},{"id":2905678,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-01-15T16:38:31.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":12.62,"expiration_date":"2021-01-13","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-21-001770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221001770/form4.xml","form_type":"4"}},{"id":2905677,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-01-15T16:38:31.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":20000,"price":12.62,"value":252400.0,"ownership":{"direct":true},"balance_after":36600,"source":{"system":"sec-edgar","filing":"0001127602-21-001770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221001770/form4.xml","form_type":"4"}},{"id":2905676,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-01-15T16:38:31.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":15000,"price":12.62,"value":189300.0,"ownership":{"direct":true},"balance_after":16600,"source":{"system":"sec-edgar","filing":"0001127602-21-001770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760221001770/form4.xml","form_type":"4"}},{"id":2923330,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:45:27.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":213,"price":86.98,"value":18526.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14653,"source":{"system":"sec-edgar","filing":"0001209191-21-001195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121001195/doc4.xml","form_type":"4"}},{"id":2956376,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2020-12-04T16:32:42.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":5578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/2/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/2/2021."}],"balance_after":5578,"derivative":{"exercise_price":0,"exercise_date":"2021-12-02","underlying":"Ordinary Shares","underlying_shares":5578},"source":{"system":"sec-edgar","filing":"0001127602-20-030574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760220030574/form4.xml","form_type":"4"}},{"id":2956375,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2020-12-04T16:32:42.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":11509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option becomes exercisable in full on 12/2/2021."}],"balance_after":11509,"derivative":{"exercise_price":18.82,"exercise_date":"2021-12-02","expiration_date":"2030-12-02","underlying":"Ordinary Shares","underlying_shares":11509},"source":{"system":"sec-edgar","filing":"0001127602-20-030574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760220030574/form4.xml","form_type":"4"}},{"id":3019186,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T20:46:30.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":197,"price":89.74,"value":17678.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14440,"source":{"system":"sec-edgar","filing":"0001209191-20-052633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120052633/doc4.xml","form_type":"4"}},{"id":3044095,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2020-08-31T20:26:17.000Z","date":"2020-08-27","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Beginning May 20, 2011, options become exercisable in full on May 20, 2012."}],"balance_after":0,"derivative":{"exercise_price":18.97,"expiration_date":"2021-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-048766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120048766/doc4.xml","form_type":"4"}},{"id":3044094,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:26:17.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":20000,"price":94.51,"value":1890200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sale price. Actual sale prices ranged from $94.50 - $94.58."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This includes an 1,282 aggregate of  shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14243,"source":{"system":"sec-edgar","filing":"0001209191-20-048766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120048766/doc4.xml","form_type":"4"}},{"id":3044093,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:26:17.000Z","date":"2020-08-27","kind":"exercise","acquired":true,"shares":20000,"price":18.97,"value":379400.0,"ownership":{"direct":true},"balance_after":34243,"source":{"system":"sec-edgar","filing":"0001209191-20-048766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120048766/doc4.xml","form_type":"4"}},{"id":3095794,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T20:57:09.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":182,"price":103.97,"value":18922.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":14243,"source":{"system":"sec-edgar","filing":"0001209191-20-039784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120039784/doc4.xml","form_type":"4"}},{"id":3094988,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-01T18:06:02.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 29, 2020. The shares underlying the award shall vest in equal monthly installments through June 29, 2023."}],"balance_after":24000,"derivative":{"exercise_price":31.95,"expiration_date":"2030-06-28","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-20-039888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000120919120039888/doc4.xml","form_type":"4"}},{"id":3102967,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T16:27:43.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of June 18, 2021 or the date of the next annual meeting of stockholders."}],"balance_after":3000,"derivative":{"exercise_price":64.09,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-20-004618","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218020004618/primarydocument.xml","form_type":"4"}},{"id":3102966,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-22T16:27:43.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of June 18, 2021 or the date of the next annual meeting of stockholders."}],"balance_after":5653,"source":{"system":"sec-edgar","filing":"0001562180-20-004618","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218020004618/primarydocument.xml","form_type":"4"}},{"id":3102965,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-22T16:27:43.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of June 18, 2021 or the date of the next annual meeting of stockholders."}],"balance_after":4153,"source":{"system":"sec-edgar","filing":"0001562180-20-004618","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218020004618/primarydocument.xml","form_type":"4"}},{"id":3120391,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T20:16:36.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the one-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service."}],"balance_after":15000,"derivative":{"exercise_price":11.79,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-070326","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465920070326/a4.xml","form_type":"4"}},{"id":3132798,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-28T20:15:43.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":10514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":10514,"derivative":{"exercise_price":98.68,"expiration_date":"2030-05-25","underlying":"Common Stock","underlying_shares":10514},"source":{"system":"sec-edgar","filing":"0001209191-20-032583","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032583/doc4.xml","form_type":"4"}},{"id":3132797,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:15:43.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":1282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":14061,"source":{"system":"sec-edgar","filing":"0001209191-20-032583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032583/doc4.xml","form_type":"4"}},{"id":3136796,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2020-05-22T16:21:02.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2021."}],"balance_after":6104,"derivative":{"exercise_price":0,"exercise_date":"2021-05-20","underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-20-017767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760220017767/form4.xml","form_type":"4"}},{"id":3136795,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2020-05-22T16:21:02.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":12823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option becomes exercisable in full on 5/20/2021."}],"balance_after":12823,"derivative":{"exercise_price":16.85,"exercise_date":"2021-05-20","expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":12823},"source":{"system":"sec-edgar","filing":"0001127602-20-017767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202283/000112760220017767/form4.xml","form_type":"4"}},{"id":3187730,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T21:07:42.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":243,"price":73.23,"value":17794.89,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12779,"source":{"system":"sec-edgar","filing":"0001209191-20-022684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120022684/doc4.xml","form_type":"4"}},{"id":3324925,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T21:12:37.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":196,"price":87.32,"value":17114.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12536,"source":{"system":"sec-edgar","filing":"0001209191-20-000850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120000850/doc4.xml","form_type":"4"}},{"id":3376920,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-08","kind":"exercise","acquired":false,"shares":18334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Beginning May 21, 2010, options become exercisable in full on May 21, 2011."}],"balance_after":0,"derivative":{"exercise_price":12.46,"expiration_date":"2020-05-21","underlying":"Common Stock","underlying_shares":18334},"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376919,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-08","kind":"exercise","acquired":false,"shares":22884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Beginning May 21, 2010, options become exercisable in 37 installments, with the first 25.00% vesting on May 21, 2011 and the remainder vesting monthly over three years."}],"balance_after":0,"derivative":{"exercise_price":12.46,"expiration_date":"2020-05-21","underlying":"Common Stock","underlying_shares":22884},"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376918,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-07","kind":"exercise","acquired":false,"shares":1540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Beginning May 21, 2010, options become exercisable in 37 installments, with the first 25.00% vesting on May 21, 2011 and the remainder vesting monthly over three years."}],"balance_after":22884,"derivative":{"exercise_price":12.46,"expiration_date":"2020-05-21","underlying":"Common Stock","underlying_shares":1540},"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376917,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-06","kind":"exercise","acquired":false,"shares":10576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Beginning May 21, 2010, options become exercisable in 37 installments, with the first 25.00% vesting on May 21, 2011 and the remainder vesting monthly over three years."}],"balance_after":24424,"derivative":{"exercise_price":12.46,"expiration_date":"2020-05-21","underlying":"Common Stock","underlying_shares":10576},"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376916,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":18334,"price":83.87,"value":1537672.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $83.12 - $84.21."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This includes an 1,520 aggregate of  shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376915,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-08","kind":"exercise","acquired":true,"shares":18334,"price":12.46,"value":228441.64,"ownership":{"direct":true},"balance_after":30674,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376914,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":22884,"price":83.87,"value":1919281.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $83.12 - $84.21."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376913,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-08","kind":"exercise","acquired":true,"shares":22884,"price":12.46,"value":285134.64,"ownership":{"direct":true},"balance_after":35224,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376912,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-07","kind":"sale","acquired":false,"shares":1540,"price":83.6,"value":128744.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $83.50 - $83.70."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376911,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":1540,"price":12.46,"value":19188.4,"ownership":{"direct":true},"balance_after":13880,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376910,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":10576,"price":84.16,"value":890076.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sale price. Actual sale prices ranged from $84.10 - $84.30."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3376909,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:25:18.000Z","date":"2019-11-06","kind":"exercise","acquired":true,"shares":10576,"price":12.46,"value":131776.96,"ownership":{"direct":true},"balance_after":22916,"source":{"system":"sec-edgar","filing":"0001209191-19-055857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119055857/doc4.xml","form_type":"4"}},{"id":3401874,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:12:17.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":225,"price":74.23,"value":16701.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001209191-19-051639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119051639/doc4.xml","form_type":"4"}},{"id":3472985,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:33:48.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":208,"price":84.96,"value":17671.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12115,"source":{"system":"sec-edgar","filing":"0001209191-19-040315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119040315/doc4.xml","form_type":"4"}},{"id":3481395,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-06-21T16:15:16.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 19, 2019 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested."}],"balance_after":105000,"derivative":{"exercise_price":1.48,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001485003-19-000042","document":"wf-form4_156114810117022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500319000042/wf-form4_156114810117022.xml","form_type":"4"}},{"id":3487754,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T22:57:21.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the one-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service."}],"balance_after":15000,"derivative":{"exercise_price":24.68,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-19-035995","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465919035995/a4.xml","form_type":"4"}},{"id":3495655,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-10T16:22:22.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 100% on the earlier of June 6, 2020 or the date of the next annual meeting of stockholders."}],"balance_after":4000,"derivative":{"exercise_price":122.01,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-19-035789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000120919119035789/doc4.xml","form_type":"4"}},{"id":3495654,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":17401,"kind":"person","name":"DIXON WENDY L","position":1,"cik":"0001202283","reported_name":"DIXON WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T16:22:22.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest 100% on the earlier of June 6, 2020 or the date of the next annual meeting of stockholders."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-035789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000120919119035789/doc4.xml","form_type":"4"}}],"next_cursor":"2019-06-10T16:22:22.000000Z,3495654"}